Takhampunya, Ratree
Ngonsawan, Wasinee
Longkunan, Asma
Phasomkusolsil, Siriporn
Promsathaporn, Sommai
Tippayachai, Bousaraporn
Sakolvaree, Jira
Mann, Alyssa N.
Lindroth, Erica J.
Funding for this research was provided by:
Armed Forces Health Surveillance Branch, Global Emerging Infections Surveillance and Response System (AFHSB-GEIS), Silver Spring, Maryland, USA (P0035_24_AF, P0035_24_AF, P0035_24_AF, P0035_24_AF, P0035_24_AF, P0035_24_AF, P0035_24_AF, P0035_24_AF, P0035_24_AF)
Article History
Received: 5 November 2024
Accepted: 21 February 2025
First Online: 2 March 2025
Declarations
:
: The authors declare no competing interests.
: All procedures involving mice and experimental manipulations were performed under an Institutional Animal Care and Use Committee (IACUC) approved protocol (PN#21-13). Research was conducted in compliance with the Animal Welfare Act and other federal statutes and regulations related to animals and experiments involving animals, and adhered to principles outlined in the “Guide for the Care and Use of Laboratory Animals,” NRC Publication, 2011 edition. All animal care and handling was conducted by licensed veterinarians and laboratory animal technicians at WRAIR-AFRIMS. All mice were humanely euthanized using carbon dioxide in accordance with the WRAIR-AFRRIMS Safety Standard Operating Procedure (SOP), titled “Euthanasia of Rodents" following the AVMA Guidelines for the Euthanasia of Animals: 2020 Edition. All methods are reported in accordance with ARRIVE guidelines.